Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Postoperative Heme Oxygenase Induction and Carbon Monoxide Production as a Novel Method to Assess Hepatic Regeneration and Predict Hepatic Related Morbidity After Partial Hepatectomy

NCT06681818 is registered in ClinicalTrials.gov with Englewood Hospital and Medical Center as lead sponsor.

NCT NCT06681818
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06681818 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Postoperative Heme Oxygenase Induction and Carbon Monoxide Production as a Novel Method to Assess Hepatic Regeneration and Predict Hepatic Related Morbidity After Partial Hepatectomy
Lead sponsor
Englewood Hospital and Medical Center
Phase
Not applicable
Overall status
Recruiting
Start date
November 21, 2025
Completion date
January 1, 2039
Enrollment
125 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

liver cancer adult, liver regeneration